https://journalofsopi.com/index.php/sopi/issue/feed Journal of Pharmacovigilance & Drug Safety 2026-01-02T14:44:06+00:00 Dr. Yogesh Kumar Goyal, MD editorjournalsopi@gmail.com Open Journal Systems <p style="text-align: justify;">In the modern era of clinical application of knowledge of pharmacology, it is a big dilemma in hoosing between the good and the best drug. In making a decision for treatment planning clinician must consider the additional features of local and systemic issues, patient's economic status as well as potential adverse effect of the drug.</p> <p style="text-align: justify;">There are large number of drug trial going on world wide to observe the effect of a particular drug or a molecule. However, the scenario has changed drastically in last 20 years. What it was with the western/ developed world is now shifting over to developing world.</p> <p style="text-align: justify;">India is set to grab clinical trial business, making the subcontinent world's preferred destination for clinical trials. The big reason being low cost of trial along with friendly drug control system with&nbsp;competent work force and patient availability. Indian investigators and clinical trial research professionals have already demonstrated their medical and scientific skills in various global clinical trials. It is time now to capitalize on this opportunity. Indian investigators and research professionals can prove their ability and show to the world and register their presence now as well as for future.</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p> https://journalofsopi.com/index.php/sopi/article/view/161 Ma??l Sha??r (Barley Water): Traditional Unani Perspectives Integrated with Phytochemistry and Modern Clinical Insights 2025-12-13T10:20:54+00:00 Samreen Farha mohdqais26@gmail.com Mohammad Saad Ahmad Khan mohdqais26@gmail.com 2025-12-13T00:00:00+00:00 Copyright (c) 2025 Samreen Farha, Mohammad Saad Ahmad Khan https://journalofsopi.com/index.php/sopi/article/view/162 Emerging Frontiers in Pharmacovigilance: Harnessing Digital Innovations and AI for Enhanced Drug Safety Monitoring in Modern and Traditional Medicine 2025-12-13T16:16:14+00:00 Arshad Hasan dr.arshadhasan@yahoo.com Ishrat Fatma dr.arshadhasan@yahoo.com <p>Pharmacovigilance, the science of detecting, assessing, understanding, and preventing adverse drug reactions (ADRs), has evolved significantly since its formal inception following the thalidomide tragedy. This review examines the historical progression of pharmacovigilance, highlighting the limitations of traditional methods and the paradigm shifts driven by technological advancements. It explores the transformative role of digital technologies, including big data analytics, social media integration, and mobile health (mHealth) applications, in enhancing drug safety monitoring. The application of artificial intelligence (AI) and machine learning (ML) in signal detection, natural language processing (NLP), and the development of AI-enabled pharmacovigilance platforms are critically assessed, emphasizing their potential to improve the speed and accuracy of ADR identification. Furthermore, this review addresses the unique challenges and strategies for pharmacovigilance in traditional medicine, where safety profiles are often underreported. It investigates the importance of integrating digital and AI-driven tools to monitor traditional remedies, including the use of blockchain for supply chain transparency. Finally, the review discusses current regulatory frameworks and the importance of global collaboration in establishing standardized pharmacovigilance practices. By synthesizing historical perspectives with emerging digital innovations, this paper underscores the importance of a comprehensive, inclusive approach to drug safety monitoring, aimed at optimizing patient outcomes and reinforcing public trust in both modern and traditional medicinal products.</p> 2025-12-13T16:14:52+00:00 Copyright (c) 2025 Arshad Hasan, Ishrat Fatma https://journalofsopi.com/index.php/sopi/article/view/166 Report on 5th National Pharmacovigilance Week celebration by ADR Monitoring Centre, JNMC, AMU, Aligarh 2025-12-24T08:30:03+00:00 Syed Ziaur Rahman mohdqais26@gmail.com Gufran Ali mohdqais@gmal.com Rashaad Ahmad Khan mohdqais@gmail.com 2025-12-24T08:30:03+00:00 Copyright (c) 2025 Syed Ziaur Rahman, Gufran Ali, Rashaad Ahmad Khan https://journalofsopi.com/index.php/sopi/article/view/167 2026-01-02T14:44:06+00:00 Syed Ziaur Rahman mohdqais26@gmail.com Gufran Ali mohdqais26@gmail.com Rashaad Ahmad Khan mohdqais26@gmail.com <p>Every year, #MedSafetyWeek brings together people from around the world to focus on one shared message: medicines are most effective when they are also safe1. This simple idea carries great importance, especially in countries like India where the use of medicines is widespread across diverse healthcare settings. This year, Aligarh, a small city in the state of Uttar Pradesh, contributed thoughtfully to the global conversation. A special programme was organised by the Adverse Drug Reaction Monitoring Centre (AMC) at Ibn Sina Academy and Jawaharlal Nehru Medical College (JNMC), in collaboration with the Society of Pharmacovigilance, India (SoPI). The event took place under the guidance of the Pharmacovigilance Programme of India (PvPI), coordinated by the Indian Pharmacopoeia Commission (IPC), which also serves as a National Coordinating Centre for Pharmacovigilance Programme of India (PvPI).</p> 2025-12-24T08:38:12+00:00 Copyright (c) 2025 Syed Ziaur Rahman, Gufran Ali, Rashaad Ahmad Khan